Based on the upregulation of circEPSTI1 in HER2-positive breast cancer, si-circEPSTI1 was transfected to knock down circEPSTI1 to explore its biological function in HER2-positive breast cancer SKBR3 and BT474 cells. Here, ERBB2 is linked to breast carcinoma.